NCT04538014View on ClinicalTrials.gov

A Study in Healthy Men to Investigate Uptake and Distribution of Lu AF88434 in the Brain

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 24, 2020

Primary Completion Date

October 21, 2020

Study Completion Date

October 21, 2020

Conditions
Healthy
Interventions
DRUG

Lu AF88434

Oral solution

DRUG

[11C]-Lu AF88434

\[11C\]-Lu AF88434, and a radioactive dose not exceeding 400 MBq at each PET examination, intravenous bolus injection

Trial Locations (1)

HA1 3UJ

Parexel International Northwick Park Hospital (Level 7), Middlesex

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT04538014 - A Study in Healthy Men to Investigate Uptake and Distribution of Lu AF88434 in the Brain | Biotech Hunter | Biotech Hunter